Today: 13 June 2026

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Kohl’s stock slides 5% as tariff ruling delay hits retailers; KSS traders eye Jan. 14

Kohl’s stock slides 5% as tariff ruling delay hits retailers; KSS traders eye Jan. 14

Kohl’s shares fell 5.1% to $20.66 Friday afternoon, underperforming retail peers, after the Supreme Court delayed a decision on Trump-era tariffs. The broader market steadied following a softer jobs report, with nonfarm payrolls up 50,000 in December and unemployment at 4.4%. Investors remain uncertain about potential $150 billion in tariff refunds as the next court ruling is expected Jan. 14.
9 January 2026
Star Bulk Carriers (SBLK) stock drops nearly 5% as dry-bulk freight gauge slips

Star Bulk Carriers (SBLK) stock drops nearly 5% as dry-bulk freight gauge slips

Star Bulk Carriers shares dropped 4.8% to $19.76 by early afternoon Friday as the Baltic Dry Index slid to 1,688, down 31% in a month. The company last reported Q4 2025 TCE at $19,500 per day and paid a $0.11 dividend for Q3. Investors await the next results update on Feb. 25. Genco Shipping fell 3.7%, while Safe Bulkers and Diana Shipping edged higher.
Establishment Labs stock slides 5%: traders eye Motiva FDA next steps and JPM conference talk

Establishment Labs stock slides 5%: traders eye Motiva FDA next steps and JPM conference talk

Establishment Labs shares fell about 5% to $69.22 in early Friday trading, reversing part of a 10% gain earlier in the week. The drop came as broader U.S. markets rose on a softer December jobs report. Investors are watching for updates at the company’s Jan. 14 J.P. Morgan Healthcare Conference presentation and awaiting FDA review of its Motiva breast implants.
9 January 2026
Qfin Holdings (QFIN) stock slides as China fintech ADRs lag on tariff limbo, credit jitters

Qfin Holdings (QFIN) stock slides as China fintech ADRs lag on tariff limbo, credit jitters

Qfin Holdings shares dropped 4.5% to $17.32 in Friday afternoon trading, hitting a session low of $17.21. FinVolution and LexinFintech also declined, as investors weighed U.S. tariff uncertainty and concerns over rising Chinese consumer loan defaults. China’s regulator recently extended a program for banks to offload bad loans. The broader U.S. market traded higher.
Why Soleno Therapeutics stock is down today: investor alerts revive Vykat XR scrutiny

Why Soleno Therapeutics stock is down today: investor alerts revive Vykat XR scrutiny

Soleno Therapeutics shares fell 5.6% to $42.95 Friday, underperforming the biotech sector after law firms announced “investigations” tied to past short-seller claims about Vykat XR. The company reported $66 million in quarterly revenue from the drug, approved for Prader-Willi syndrome, with 1,043 patient start forms since March. The stock hovered just above its 52-week low. Next update expected late February.
Wave Life Sciences (WVE) stock slides 6% even as biotech ETFs rise — what’s driving it now

Wave Life Sciences (WVE) stock slides 6% even as biotech ETFs rise — what’s driving it now

Wave Life Sciences shares dropped 5.6% to $14.00 on Friday, underperforming biotech ETFs. The decline follows a $350 million stock offering and comes ahead of new obesity drug trial data expected later in 2026. Investors remain focused on dilution risks and upcoming updates from management. CEO Paul Bolno will present at the J.P. Morgan Healthcare Conference on January 13.
9 January 2026
Gold price today: 24K jumps to ₹137,122/10g, silver back above ₹242,000/kg after whipsaw

Gold price today: 24K jumps to ₹137,122/10g, silver back above ₹242,000/kg after whipsaw

India’s benchmark 24-carat gold rate rose 1,349 rupees to 137,122 rupees per 10 grams Friday, according to IBJA, while silver jumped 6,982 rupees to 242,808 rupees per kg. Dealers reported premiums on gold fell to $6 an ounce as demand cooled. MCX February gold futures last traded at 137,729 rupees, with a high of 138,951. Spot gold globally rose 0.6% to $4,502.98 an ounce.
Why Immunome stock is up today: IMNM jumps 7% as biotech firms up and JPM conference looms

Why Immunome stock is up today: IMNM jumps 7% as biotech firms up and JPM conference looms

Immunome shares rose 7.4% to $21.97 Friday after recent Phase 3 data showed its lead drug varegacestat cut disease progression or death by 84% in desmoid tumor patients. The company plans to file for FDA approval in Q2 2026. Immunome also granted stock options to three new hires and will present at the J.P. Morgan Healthcare Conference on Jan. 14.
SoundHound AI stock jumps 9% as CES 2026 headlines collide with a fresh DA Davidson target cut

SoundHound AI stock jumps 9% as CES 2026 headlines collide with a fresh DA Davidson target cut

SoundHound AI shares rose about 9% to $12.01 by midday Friday, trading on heavy volume after CES demos and a new partnership with TomTom. The move followed a price target cut by D.A. Davidson, citing complex sales plans. SoundHound posted a $109.3 million net loss in Q3 and held $269 million in cash at the end of September. The company has not confirmed its next earnings date.
Builders FirstSource (BLDR) stock jumps as Trump’s $200B mortgage-bond order jolts housing names

Builders FirstSource (BLDR) stock jumps as Trump’s $200B mortgage-bond order jolts housing names

Builders FirstSource shares surged 10.8% to $123.27 after President Trump ordered $200 billion in mortgage bond purchases to lower rates. The move sparked a rally in housing-linked stocks. Federal officials said Fannie Mae and Freddie Mac would handle the bond buys but gave few details. Investors are watching for execution updates and the company’s earnings report expected February 19.
Hawaiian Electric stock jumps toward $15 after BlackRock stake filing and Maui wildfire settlement update

Hawaiian Electric stock jumps toward $15 after BlackRock stake filing and Maui wildfire settlement update

Hawaiian Electric Industries shares rose about 9% to $14.91 in New York midday trading Friday after news of a preliminary $47.75 million shareholder settlement over wildfire disclosures. BlackRock disclosed a 16.1% stake as of Dec. 31. The company’s gain outpaced major utility peers. A key Hawai‘i Supreme Court hearing in a related case is set for Jan. 27.
9 January 2026
Compass stock jumps nearly 9% as Anywhere merger closes — here’s what traders watch next

Compass stock jumps nearly 9% as Anywhere merger closes — here’s what traders watch next

Compass shares jumped nearly 9% after closing its all-stock merger with Anywhere Real Estate and selling $1 billion in convertible notes. The combined firm now spans about 340,000 real estate professionals. Compass updated guidance, projecting Q4 revenue at the high end of its prior range and adjusted EBITDA above earlier outlooks. Anywhere’s shares have been delisted from the NYSE.
1 274 275 276 277 278 590

Stock Market Today

  • Caledonia Mining Reports High Grade Motapa Drilling Amid Depressed Shares
    June 13, 2026, 3:48 PM EDT. Caledonia Mining (NYSEAM:CMCL) announced significant high grade gold drilling results from its 2025 exploration at Motapa, Zimbabwe, revealing continuous mineralised zones near the Bilboes Gold Project. This proximity offers potential operational synergies and shared infrastructure, with a maiden resource estimate pending to clarify Motapa's role in Caledonia's production plans. Despite this, shares trade at $20.18, down 18.5% in the last month and 23.4% year-to-date, and currently about 53% below the $42.73 analyst target price. Investors should monitor the upcoming resource estimate and integration efforts between Motapa and Bilboes, noting execution risks in permitting and development remain. The stock is also estimated to trade nearly 24% below fair value, suggesting a discounted entry point amid mixed market sentiment.

Latest articles

KLA Jumps After 10-for-1 Stock Split; AI Chip Boom Lifts Hopes on Tools

KLA Jumps After 10-for-1 Stock Split; AI Chip Boom Lifts Hopes on Tools

13 June 2026
KLA soared 5.55% to $254.54 on its first split-adjusted day after a 10-for-1 stock split and analyst price target hikes tied to AI-driven chip equipment demand, but with the stock now above several split-adjusted targets, investors face heightened risk ahead of the fiscal Q4 report, which will be the next key catalyst for revenue, earnings, and AI-linked demand guidance.
Pfizer trades around $26 with dividend in focus, drug-price worries linger

Pfizer trades around $26 with dividend in focus, drug-price worries linger

13 June 2026
Pfizer closed at $26.21, up 0.15%, outperforming the Health Care Select Sector SPDR ETF despite new German drug-pricing pressures and a European legal setback; investors are focused on the 6.56% dividend yield, reaffirmed 2026 guidance, and pipeline progress in obesity and oncology as Q2 earnings on August 4 approach.
Go toTop